Managing lorlatinib together: An overview and practical guide for patients by ALK-positive NSCLC patients and medical experts

Nancee Pronsati, Geoffrey Liu, Todd M. Bauer, Enriqueta Felip, Yasushi Goto, Gerald Green, Mary Grizzard, Michael Hamel, Julien Mazieres, Tony Mok, Stephanie Snow, Benjamin J. Solomon, Jan Stratmann, Ken Culver

Open source

DOI
10.1016/j.lungcan.2025.108662
Published
2025-08
Container
Lung Cancer
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lungcan.2025.108662,
  title = {Managing lorlatinib together: An overview and practical guide for patients by ALK-positive NSCLC patients and medical experts},
  author = {Nancee Pronsati and Geoffrey Liu and Todd M. Bauer and Enriqueta Felip and Yasushi Goto and Gerald Green and Mary Grizzard and Michael Hamel and Julien Mazieres and Tony Mok and Stephanie Snow and Benjamin J. Solomon and Jan Stratmann and Ken Culver},
  year = {2025},
  journal = {Lung Cancer},
  doi = {10.1016/j.lungcan.2025.108662},
  url = {https://doi.org/10.1016/j.lungcan.2025.108662}
}

RIS

TY  - JOUR
TI  - Managing lorlatinib together: An overview and practical guide for patients by ALK-positive NSCLC patients and medical experts
AU  - Nancee Pronsati
AU  - Geoffrey Liu
AU  - Todd M. Bauer
AU  - Enriqueta Felip
AU  - Yasushi Goto
AU  - Gerald Green
AU  - Mary Grizzard
AU  - Michael Hamel
AU  - Julien Mazieres
AU  - Tony Mok
AU  - Stephanie Snow
AU  - Benjamin J. Solomon
AU  - Jan Stratmann
AU  - Ken Culver
PY  - 2025
JO  - Lung Cancer
DO  - 10.1016/j.lungcan.2025.108662
UR  - https://doi.org/10.1016/j.lungcan.2025.108662
ER  - 

APA

Pronsati, N., Liu, G., Bauer, T. M., Felip, E., Goto, Y., Green, G., Grizzard, M., Hamel, M., Mazieres, J., Mok, T., Snow, S., Solomon, B. J., Stratmann, J., & Culver, K. (2025). Managing lorlatinib together: An overview and practical guide for patients by ALK-positive NSCLC patients and medical experts. Lung Cancer. https://doi.org/10.1016/j.lungcan.2025.108662

Source records